Quest Diagnostics
Submit RFI/RFPQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 44,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
Visit http://www.questdiagnostics.com/home/about for more information.
Contact Address | Edificio Federal Frente al Hospital Hermanos Melendez, Bayamon PR 00960 US |
Phone Number | 787-787-7577 |
NA | |
Website | http://www.questdiagnostics.com/home.html |
Category | Value Based Care |
Products & Solutions
Products & Solutions | Diagnostic Testing and Services, Clinical Testing, Cancer Diagnostics and Anatomic Pathology Services, Gene-based and other Esoteric Testing, Healthcare Technology Solutions. |
Services
Services | Diagnostic Testing Services, Healthcare IT, Wellness and Risk Management, Clinical Trials Testing |
Key Executives
![]() |
Stephen H. Rusckowski President and Chief Executive Officer
Since joining Quest Diagnostics in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of Empowering better health with diagnostic insights. Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. |
![]() |
Jay G. Wohlgemuth, M.D., is Chief Medical Officer and Senior Vice President, Research & Development and Medical for Quest Diagnostics.
Based at Quest Diagnostics Nichols Institute, in San Juan Capistrano, California, Dr. Wohlgemuth is responsible for Research & Development (R&D), Medical Affairs, and Medical/Lab Quality. In addition, he is responsible for improving outcomes for employees who use our health benefits. Dr. Wohlgemuth has many years of experience in medical diagnostics and research and development. He rejoined Quest in 2016 from HealthTap, a health information start-up, where he served as Senior Vice President and Chief Healthcare Officer. |
White Papers & Resources
Resources | Drug Testing Resource, Industry Expert Resources |
More Like This

When it comes to healthcare, Allied Telesis is the industry leader in providing cost-effective, reli...

Preventice Solutions, a leading developer of mobile health solutions and services, was created by a ...

Acupera is a leading provider of digital health solutions that enable healthcare provider organizati...

Copatient provides a comprehensive solution for managing and minimizing healthcare expenses. Copatie...

DataMetrix was formed in 2005 by Mary Jane LaBelle and Brent Andersonboth of whom have had exten...

Premier Healthcare Exchange | Stratose | Pay-Plus Solutions | GlobalCare, merged in 2016, creating a...

Ingenious Med is a healthcare software company that answers the question, What if? Whether i...

ITD GmbH is a medium-sized company in the electromedical engineering sector. We have developed, prod...

Founded in 2004, AMR is setting the industry standard in providing quality independent medical case ...

Agile Health is a mobile health engagement company that leverages the power of text messaging to dri...

Apixio was founded in 2009 with the vision of uncovering and making accessible clinical knowledge fr...

SonoSites first mission was to create an ultrasound machine that could be carried into battle an...

Axial Exchange helps health systems stay better connected to their patients and community. Our mobil...